|
|
||||||||
LIVER AND BILIARY TRACT
Institut National de la Santé et de la Recherche Médicale U522, Hôpital Pontchaillou, 35033 Rennes, France
Submitted 29 July 2002 ; accepted in final form 13 March 2003
Unlike a large number of cell types that undergo terminal differentiation associated with permanent withdrawal from the cell cycle, mature quiescent hepatocytes retain high proliferative potential. We report here a specific behavior of members of the Cip/Kip family of cyclin-dependent kinase (Cdk) inhibitors during development of the rat liver and proliferation of normal hepatocytes. Expression of p21, p27, and p57 transcripts and proteins was downregulated during the differentiation process to low or undetectable levels in adult liver. In contrast to p27, p21 protein increased in a mitogen-dependent manner in isolated hepatocytes and its expression pattern correlated with that of cyclin D1. In proliferating hepatocytes, p21 was predominantly associated with cyclin D1, these proteins were colocalized in the nucleus and p21-associated retinoblastoma protein (pRb) kinase activity increased in parallel with that of cyclin D1. Overexpression of p21 in mitogen-stimulated hepatocytes reduced DNA synthesis. In contrast, inhibition of p21 expression by antisense or small interfering RNAs oligonucleotides accelerated S phase entry. Finally, expression of p21 and cyclin D1, but not p27 proteins was regulated by MAPK kinase/extracellular signal-regulated kinase and phosphatidylinositol 3-kinase-ferric-reducing ability power/mammalian target of rapamycin signal transduction pathways. In conclusion, these results demonstrate a specific and differential regulation of p21 and p27 during hepatocyte differentiation and proliferation that may contribute to the control of quiescent differentiated hepatic cell proliferating activity.
liver; hepatocyte growth control; signal transduction
This article has been cited by other articles:
![]() |
F. Barchiesi, E. K. Jackson, J. Fingerle, D. G. Gillespie, B. Odermatt, and R. K. Dubey 2-Methoxyestradiol, an Estradiol Metabolite, Inhibits Neointima Formation and Smooth Muscle Cell Growth via Double Blockade of the Cell Cycle Circ. Res., August 4, 2006; 99(3): 266 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Majka, K. Fox, B. McGuire, J. Crossno Jr., P. McGuire, and A. Izzo Pleiotropic role of VEGF-A in regulating fetal pulmonary mesenchymal cell turnover Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1183 - L1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Biecker, A. De Gottardi, M. Neef, M. Unternahrer, V. Schneider, M. Ledermann, H. Sagesser, S. Shaw, and J. Reichen Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 952 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Chen, E. G. Neilson, and R. C. Harris Role of Mammalian Target of Rapamycin Signaling in Compensatory Renal Hypertrophy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1384 - 1391. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |